The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis. O...

Descripción completa

Detalles Bibliográficos
Autores principales: de Miranda, Mirela Costa, Haddad, Luciana Bertocco de Paiva, Trindade, Evelinda, Cassenote, Alex, Hayashi, Giselle Y., Damiani, Durval, Costa, Fernanda Cavalieri, Madureira, Guiomar, de Mendonca, Berenice Bilharinho, Bachega, Tania A. S. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183606/
https://www.ncbi.nlm.nih.gov/pubmed/34109139
http://dx.doi.org/10.3389/fped.2021.659492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183606/
https://www.ncbi.nlm.nih.gov/pubmed/34109139
http://dx.doi.org/10.3389/fped.2021.659492

Ejemplares similares